M & H


Concise Prescribing Info
Lower resp tract infections eg, bronchitis & pneumonia, odontostomatological, skin & soft tissue infections, acute otitis media, upper resp tract infection eg, sinusitis & S pyogenes pharyngitis/tonsillitis. Uncomplicated genital infection due to Chlamydia trachomatis & non-multiresistant Neisseria gonorrhoea & chancroid due to Haemophilus ducreyi. Prophylaxis against Mycobacterium avium-intracellulare complex (MAC) alone or in combination w/ rifabutin. In combination w/ ethambutol for disseminated MAC (DMAC).
Dosage/Direction for Use
Adult STD caused by Chlamydia trachomatis, Haemophilus ducreyi or susceptible Neisseria gonorrhoea 1,000 mg as single oral dose. Prophylaxis against MAC infections HIV 1,200 mg once/wk. DMAC infections Advanced HIV 600 mg daily in combination w/ antimycobacterial agents eg, ethambutol at the approved dose. Other indications Total dose of 1,500 mg given as 500 mg daily for 3 days. Childn >45 kg & elderly Same as adult dose.
Should be taken on an empty stomach: Take at least 1 hr before or 2 hr after meals or Al- & Mg-containing antacids.
Hypersensitivity to any macrolide antibiotics.
Special Precautions
Allergic reactions; patients receiving ergot derivative. Observe for signs of superinfection w/ non-susceptible organisms eg, fungi. Significant hepatic disease. Severe renal impairment. Pregnancy & lactation.
Adverse Reactions
GI disturbances, mild neutropenia, abnormal liver function, allergic reactions, hearing impairment. Frequently in HIV patients: Diarrhea, abdominal pain, nausea, loose stools, flatulence, vomiting, dyspepsia, rash, pruritus & arthralgia. Asthenia, severe cutaneous adverse reactions including Stevens-Johnson syndrome, toxic epidermal necrolysis, drug reaction w/ eosinophilia & systemic symptoms & acute generalized exanthematous pustulosis.
Drug Interactions
Impaired metabolism of digoxin. Little effect on plasma pharmacokinetics or urinary excretion of zidovudine. Possibility of ergotism w/ ergot derivatives. Monitor cyclosporin levels. Neutropenia was observed w/ rifabutin. Possible interaction w/ terfenadine.
MIMS Class
ATC Classification
J01FA10 - azithromycin ; Belongs to the class of macrolides. Used in the systemic treatment of infections.
Azithro cap 250 mg
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in